Web Application Allows Physicians to Analyze Vasculature

Having the ability to utilize these tools over the web brings additional advantages because physicians can access images from home computers and laptops, providing freedom to work anywhere, even when an advanced clinical application or analysis is required.

Calgary Scientific, Inc. (Calgary, Alberta, Canada) has received clearance from the US Food and Drug Administration (FDA) to market its industry-leading ResolutionMD Web 2.9 Vessel Analysis module for postprocessing diagnostic review and analysis of patient computed tomography (CT) and magnetic resonance imaging (MRI) scans.

“ResolutionMD Vessel Analysis enables our technologists to efficiently prepare sophisticated CT and MR vascular studies for our hospital clients,” said Dr. Robert Falk, medical director, 3DR Laboratories, LLC (Louisville, KY, USA). “The tools are easy and intuitive to use, and let us quickly isolate vessels for visualization and measurements. The browser-based client provides the ultimate accessibility, not only for our technologists to prepare cases for interpretation, but also for our customer hospitals and physicians.”

“We believe in the rigor of the FDA clearance process and are proud to have another product receive this significant regulatory approval,” stated Kyle Peterson, director of Government and Regulatory Affairs for Calgary Scientific. “Calgary Scientific will continue to aggressively pursue clearances from the FDA and are already working towards growing our cleared platforms and extending the clearance to other product functionality.”

Calgary Scientific is focused on providing advanced web, mobility, and multiparty collaboration enablement-platform technology, as well as advanced visualization solutions to industries looking for secure access and use of their data or graphics-intensive applications, while using their existing systems.

Related Links:
Calgary Scientific